【获批】超10亿注射剂，石家庄四药成功拿下

米内网2025-12-17

精彩内容近日，石四药集团发布公告称，公司的复方醋酸钠林格注射液和乙酰半胱氨酸注射液成功获批，今年以来已累计有51个新品上市，成绩亮眼。2025年Q1-Q3在中国公立医疗机构终端，复方醋酸钠林格注射液是血液代用品和灌注液TOP8产品，乙酰半胱氨酸注射液是胆、肝疾病治疗药TOP19产品。图1：石家庄四药最新获批的产品情况来源：国家药监局官网复方醋酸钠林格注射液主要用于循环血容量及组织间液减少时细胞外液...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2592949153?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-17 16:10","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2592949153","market":"hk","top_or_hot":-1,"title":"【获批】超10亿注射剂，石家庄四药成功拿下","media":"米内网","content":"<div>\n<p>精彩内容近日，石四药集团发布公告称，公司的复方醋酸钠林格注射液和乙酰半胱氨酸注射液成功获批，今年以来已累计有51个新品上市，成绩亮眼。2025年Q1-Q3在中国公立医疗机构终端，复方醋酸钠林格注射液是血液代用品和灌注液TOP8产品，乙酰半胱氨酸注射液是胆、肝疾病治疗药TOP19产品。图1：石家庄四药最新获批的产品情况来源：国家药监局官网复方醋酸钠林格注射液主要用于循环血容量及组织间液减少时细胞外液...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162232a6ad1739&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【获批】超10亿注射剂，石家庄四药成功拿下</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【获批】超10亿注射剂，石家庄四药成功拿下\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-17 16:10 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162232a6ad1739&s=b><strong>米内网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>精彩内容近日，石四药集团发布公告称，公司的复方醋酸钠林格注射液和乙酰半胱氨酸注射液成功获批，今年以来已累计有51个新品上市，成绩亮眼。2025年Q1-Q3在中国公立医疗机构终端，复方醋酸钠林格注射液是血液代用品和灌注液TOP8产品，乙酰半胱氨酸注射液是胆、肝疾病治疗药TOP19产品。图1：石家庄四药最新获批的产品情况来源：国家药监局官网复方醋酸钠林格注射液主要用于循环血容量及组织间液减少时细胞外液...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162232a6ad1739&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162232a6ad1739&s=b","article_id":"2592949153","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162232a6ad1739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2592949153","pubTimestamp":1765959048,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"精彩内容近日，石四药集团发布公告称，公司的复方醋酸钠林格注射液和乙酰半胱氨酸注射液成功获批，今年以来已累计有51个新品上市，成绩亮眼。乙酰半胱氨酸注射液主要用于急性对乙酰氨基酚中毒解毒，预防或减轻其过量引起的肝脏损伤。早前，石家庄四药在胆、肝疾病治疗药市场已有复方甘草酸单铵S氯化钠注射液，乙酰半胱氨酸注射液是公司在该类药物市场第二个获批的产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1191":"制药","02005":"石四药集团","LU2460026573.USD":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC"},"translate_title":"[Approved] Over 1 billion injections, Shijiazhuang Four Medicines successfully won","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02005":0.9},"content_text":"精彩内容近日，石四药集团发布公告称，公司的复方醋酸钠林格注射液和乙酰半胱氨酸注射液成功获批，今年以来已累计有51个新品上市，成绩亮眼。2025年Q1-Q3在中国公立医疗机构终端，复方醋酸钠林格注射液是血液代用品和灌注液TOP8产品，乙酰半胱氨酸注射液是胆、肝疾病治疗药TOP19产品。图1：石家庄四药最新获批的产品情况来源：国家药监局官网复方醋酸钠林格注射液主要用于循环血容量及组织间液减少时细胞外液的补充及代谢性酸中毒的纠正，目前该产品的竞争企业（国产）超过10家。图2：复方醋酸钠林格注射液的销售情况（单位：万元）来源：米内网中国公立医疗机构终端竞争格局在中国城市公立医院、县级公立医院、城市社区中心及乡镇卫生院（简称中国公立医疗机构）终端，复方醋酸钠林格注射液的销售额在2021-2024年保持在11亿元水平，抗压能力极强，2025年Q1-Q3跌幅在2%左右，潜力依然可期。2025年Q1-Q3，该产品是血液代用品和灌注液（化+生）市场TOP8产品。2025年Q1-Q3在血液代用品和灌注液（化+生）市场，石家庄四药是TOP7集团（一级），重磅新品上市将助力公司进一步提升竞争力。乙酰半胱氨酸注射液主要用于急性对乙酰氨基酚中毒解毒，预防或减轻其过量引起的肝脏损伤。米内网数据显示，目前乙酰半胱氨酸注射液的竞争企业（进口+国产）有6家，石家庄四药是该产品第三家过评企业。图3：乙酰半胱氨酸注射液的过评企业来源：米内网中国上市药品（MID）数据库在中国公立医疗机构终端，乙酰半胱氨酸注射液曾在2021年大卖超10亿元，2022年至今持续下滑，2024年降至5.7亿元左右，2025年Q1-Q3是胆、肝疾病治疗药（化+生）市场TOP19产品。早前，石家庄四药在胆、肝疾病治疗药市场已有复方甘草酸单铵S氯化钠注射液，乙酰半胱氨酸注射液是公司在该类药物市场第二个获批的产品。表1：今年以来石家庄四药获批的新产品来源：米内网中国上市药品（MID）数据库","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592949153","isCrawlerRequest":true}